Blood BanK

SpotSee’s HemoTemp II receives standards accreditation from AABB

A step further in ensuring supply chain integrity for blood during transit and storage outside blood banks...

Mayo Clinic Labs and Progentec® Partner for Advanced Autoimmune Biomarker Testing

The collaboration aims to increase accessibility for providers and patients across the U.S. and select global markets....

GE Healthcare and Novo Nordisk Team Up for Non-Invasive Diabetes & Obesity Treatment

GE HealthCare a collaboration with Novo Nordisk to further advance the clinical and product development of peripheral focused ultrasound (PFUS). This is a novel technology that has potential to specifically regulate metabolic function in the body using ultrasound that may support the treatment of chronic diseases such as type 2 diabetes and obesity....

FloBio's Bleeding Risk Diagnostic Test Earns FDA's Breakthrough Device Designation

Rapid Detection of Modern Blood Thinners Could Reduce Preventable Complications in US Hospitals...

Labcorp Launches New Test to Accelerate Path to Diagnosis of Alzheimer's Disease

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced the launch and national availability of its ATN Profile, a blood-based test that combines three, well-researched blood biomarkers to identify and assess biological changes associated with Alzheimer's disease – amyloid plaques, tau tangles and neurodegeneration (ATN) – which can help accelerate the path to diagnosis and intervention.i The test is available through physicians for use with patients ...

DELFI Diagnostics Introduces FirstLook Lung: A Breakthrough in Blood-Based Lung Cancer Screening

FirstLook Lung uses a breakthrough technology of whole-genome machine learning to analyze fragments of cell-free DNA that are markers of cancer in the blood...

How blood-based protein biomarkers enable early detection and intervention of Alzheimer’s disease

Blood-based protein biomarkers have emerged as a promising tool for the early detection of Alzheimer's disease...

Mirxes receives US FDA’s breakthrough device designation for blood-based cancer detection test

GASTROClear is the first miRNA blood test and the first gastric cancer molecular test globally to receive FDA Breakthrough Device Designation...

Improved Access to Alzheimer's Blood Test Through Beckman Coulter-Fujirebio Partnership

Collaboration Builds upon Fujirebio Expertise in Neurodegenerative Disease Assays and Beckman Coulter’s High Sensitivity, High Throughput, Global Installed Base of Access Family of Immunoassay Analyzers...